Coombs negative autoimmune hemolytic anemia in Crohn's disease

Bong Soo Park1, Sihyung Park1, Kyubok Jin1

  • 1Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

Insights

Autoimmune hemolytic anemia (AIHA) is rare in Crohn's disease patients. This case highlights a rare Coombs-negative AIHA diagnosis in a Crohn's patient, identified by elevated red blood cell-bound immunoglobulin G (RBC-IgG) and successfully treated with steroids.

Area of Science:

  • Gastroenterology
  • Hematology
  • Immunology

Background:

  • Anemia is a frequent complication of Crohn's disease (CD), with iron deficiency and anemia of chronic disease being most common.
  • Autoimmune hemolytic anemia (AIHA), particularly the Coombs-negative variant, is an exceptionally rare form of anemia in CD patients.

Observation:

  • A 41-year-old woman with well-controlled Crohn's disease presented with symptoms suggestive of hemolysis, including dark urine, dizziness, and shortness of breath.
  • Laboratory findings revealed elevated bilirubin and lactate dehydrogenase (LDH), with undetectable haptoglobin, indicative of hemolysis.
  • Direct and indirect Coombs tests were negative, prompting further investigation for Coombs-negative AIHA.

Findings:

  • Red blood cell-bound immunoglobulin G (RBC-IgG) levels were significantly elevated (352 IgG molecules/cell vs. cut-off 78.5 IgG molecules/cell), confirming Coombs-negative AIHA.
  • The patient's Crohn's disease activity index (CDAI) was below 100, indicating the anemia was not directly related to active disease flares.

Implications:

  • This case underscores the importance of considering Coombs-negative AIHA in Crohn's disease patients presenting with unexplained hemolytic anemia, even with controlled disease activity.
  • Diagnosis via RBC-IgG measurement is crucial for identifying this rare condition.
  • Steroid therapy proved effective in managing this rare presentation of AIHA in a Crohn's disease patient.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
824
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
16
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
738
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
176
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
16.2K